Crosslink Therapeutics Form D (2026)

Summary

The SEC Form D for Crosslink Therapeutics, filed on 2026-10-20, reports $5,500,000 raised. It was listed in the Raise Track Update of 2026-10-21. Filing: https://www.sec.gov/Archives/edgar/data/2067583/000206758326000002/0002067583-26-000002-index.htm

An earlier Form D filed 2025-05-15 reports $4,250,000 sold of $8,000,000. It is not in this issue. The amounts are not combined.

This page is not indexed by search engines yet because the filing does not name the purchasers.

Investors

Sources

Last verified: 2026-10-21

1. https://www.sec.gov/Archives/edgar/data/2067583/000206758326000002/0002067583-26-000002-index.htm
   Type: sec filing. Accessed 2026-10-21.
   SEC Form D for Crosslink Therapeutics Inc.. EDGAR filing date 2026-10-20. Signed 2026-10-20. First sale 2026-10-08. Total amount sold $5,500,000 of an offering amount of $5,500,000. 8 investors already invested. Issuer address city is Boston, Massachusetts. Jurisdiction of incorporation is Delaware. Entity type on the form is Corporation. Year of incorporation on the form: 2021. The form does not name the purchasers or a round type. Street addresses are not published. The form describes the securities as an option, warrant, or other right to acquire another security, and the security to be acquired upon exercise. The form spells the first related person Ronald D. Seidel, III. This page uses Ronald Seidel, III, the name in the Raise Track Update. An earlier Form D filed 2025-05-15 reports $4,250,000 sold of $8,000,000. It is not in this issue. The amounts are not combined.
2. https://buttondown.com/raisetrack/archive/raise-track-update-2026-10-21/
   Type: other verified public source. Accessed 2026-10-21.
   Raise Track Update for 2026-10-21, Section 3. Lists Crosslink Therapeutics, state MASSACHUSETTS, industry Pharmaceuticals, amount raised $5,500,000.